Dr. Zhang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4353 Park Terrace Dr
Ste 150
Westlake Village, CA 91361Phone+1 805-987-5300Fax+1 818-707-7668
Summary
- Dr. Xiaolin Zhang is an ophthalmologist in Thousand Oaks, CA. She received her medical degree from Rutgers Robert Wood Johnson Medical School and has been in practice 7 years. She specializes in anterior segment related and cornea & external disease and is experienced in corneal transplant surgery, cornea / external disease, dry eye, corneal infections / ulcers, and ocular surface disease.
Education & Training
- Albany Medical CenterFellowship, Cornea, External Diseases, and Refractive Surgery, 2014 - 2015
- Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Ophthalmology, 2010 - 2014
- Lehigh Valley Health NetworkInternship, Transitional Year, 2010 - 2011
- Rutgers Robert Wood Johnson Medical SchoolClass of 2010
Certifications & Licensure
- CA State Medical License 2015 - 2026
- NY State Medical License 2014 - 2016
- OH State Medical License 2011 - 2014
- PA State Medical License 2010 - 2011
- American Board of Ophthalmology Ophthalmology
Publications & Presentations
PubMed
- 13 citationsSupercritical fluid chromatography-tandem mass spectrometry for high throughput bioanalysis of small molecules in drug discovery.Xiaolin Zhang, Xiao Ding, Jianshuang Wang, Brian Dean
Journal of Pharmaceutical and Biomedical Analysis. 2019-02-05 - 49 citationsPharmacological Induction of RAS-GTP Confers RAF Inhibitor Sensitivity in KRAS Mutant TumorsIvana Yen, Frances Shanahan, Mark Merchant, Christine Orr, Thomas Hunsaker
Cancer Cell. 2018-10-08 - 16 citationsIndividual serum bile acid profiling in rats aids in human risk assessment of drug-induced liver injury due to BSEP inhibition.Steven Cepa, David Potter, Lisa Wong, Leah Schutt, Jacqueline M. Tarrant
Toxicology and Applied Pharmacology. 2018-01-01
Press Mentions
- NMPA Grants Marketing Approval to the First Co-Developed NGS-Based Companion Diagnostic for Lung Cancer in ChinaOctober 11th, 2024
- Dizal Reports Positive Phase I Data for Breast Cancer TherapySeptember 6th, 2022
- Dizal Announces Sunvozertinib Meets Primary Endpoint in Its First Pivotal Study in Platinum-Pretreated NSCLC Patients with EGFR Exon20ins Mutations at 2022 ESMOSeptember 5th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: